2018-2023 Global Influenza Diagnostics Consumption Market Report
The report requires updating with new data and is sent in 48 hours after order is placed.
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Influenza Diagnostics market for 2018-2023.
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season.
North America and Europe are the largest consumers in influenza diagnostics and is expected to retain the higher growth rate during the next years due to strong growth in influenza diagnostics industry. China has witnessed a major chunk in influenza diagnostics in the Asia Pacific region. Actually, that is why manufacturers have several plants, usually close to aimed demand market.
All manufactures in the world are committed to the improvement of products. These two years, some of Chinese manufactures can almost catch up with the world's leading technology too. Most technologies are developed by the manufacturers instead of importing from other companies.
Many international manufacturers expand their business through building factories or investments in targeted markets. Also, many major players have built up plants in other countries.
Over the next five years, LPI(LP Information) projects that Influenza Diagnostics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Diagnostics market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Research objectives
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Influenza Diagnostics market for 2018-2023.
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season.
North America and Europe are the largest consumers in influenza diagnostics and is expected to retain the higher growth rate during the next years due to strong growth in influenza diagnostics industry. China has witnessed a major chunk in influenza diagnostics in the Asia Pacific region. Actually, that is why manufacturers have several plants, usually close to aimed demand market.
All manufactures in the world are committed to the improvement of products. These two years, some of Chinese manufactures can almost catch up with the world's leading technology too. Most technologies are developed by the manufacturers instead of importing from other companies.
Many international manufacturers expand their business through building factories or investments in targeted markets. Also, many major players have built up plants in other countries.
Over the next five years, LPI(LP Information) projects that Influenza Diagnostics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Diagnostics market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
- RIDT
- RT-PCR
- Cell Culture
- Hospitals
- POCT
- Others (Laboratory diagnosis, etc.)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BD
- Abbott (Include Alere)
- Roche
- SIEMENS
- Analytik Jena
- Quidel
- Thermo Fisher
- Meridian Bioscience
- BioMerieux
- Sekisui Diagnostics
- Response Biomedical
- SA Scientific
- Enigma Diagnostics
- Focus Diagnostics
Research objectives
- To study and analyze the global Influenza Diagnostics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of Influenza Diagnostics market by identifying its various subsegments.
- Focuses on the key global Influenza Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Influenza Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Influenza Diagnostics submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Diagnostics Consumption 2013-2023
2.1.2 Influenza Diagnostics Consumption CAGR by Region
2.2 Influenza Diagnostics Segment by Type
2.2.1 RIDT
2.2.2 RT-PCR
2.2.3 Cell Culture
2.3 Influenza Diagnostics Consumption by Type
2.3.1 Global Influenza Diagnostics Consumption Market Share by Type (2013-2018)
2.3.2 Global Influenza Diagnostics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Influenza Diagnostics Sale Price by Type (2013-2018)
2.4 Influenza Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 POCT
2.4.3 Others (Laboratory diagnosis, etc.)
2.5 Influenza Diagnostics Consumption by Application
2.5.1 Global Influenza Diagnostics Consumption Market Share by Application (2013-2018)
2.5.2 Global Influenza Diagnostics Value and Market Share by Application (2013-2018)
2.5.3 Global Influenza Diagnostics Sale Price by Application (2013-2018)
3 GLOBAL INFLUENZA DIAGNOSTICS BY PLAYERS
3.1 Global Influenza Diagnostics Sales Market Share by Players
3.1.1 Global Influenza Diagnostics Sales by Players (2016-2018)
3.1.2 Global Influenza Diagnostics Sales Market Share by Players (2016-2018)
3.2 Global Influenza Diagnostics Revenue Market Share by Players
3.2.1 Global Influenza Diagnostics Revenue by Players (2016-2018)
3.2.2 Global Influenza Diagnostics Revenue Market Share by Players (2016-2018)
3.3 Global Influenza Diagnostics Sale Price by Players
3.4 Global Influenza Diagnostics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Influenza Diagnostics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Influenza Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 INFLUENZA DIAGNOSTICS BY REGIONS
4.1 Influenza Diagnostics by Regions
4.1.1 Global Influenza Diagnostics Consumption by Regions
4.1.2 Global Influenza Diagnostics Value by Regions
4.2 Americas Influenza Diagnostics Consumption Growth
4.3 APAC Influenza Diagnostics Consumption Growth
4.4 Europe Influenza Diagnostics Consumption Growth
4.5 Middle East & Africa Influenza Diagnostics Consumption Growth
5 AMERICAS
5.1 Americas Influenza Diagnostics Consumption by Countries
5.1.1 Americas Influenza Diagnostics Consumption by Countries (2013-2018)
5.1.2 Americas Influenza Diagnostics Value by Countries (2013-2018)
5.2 Americas Influenza Diagnostics Consumption by Type
5.3 Americas Influenza Diagnostics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Influenza Diagnostics Consumption by Countries
6.1.1 APAC Influenza Diagnostics Consumption by Countries (2013-2018)
6.1.2 APAC Influenza Diagnostics Value by Countries (2013-2018)
6.2 APAC Influenza Diagnostics Consumption by Type
6.3 APAC Influenza Diagnostics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Influenza Diagnostics by Countries
7.1.1 Europe Influenza Diagnostics Consumption by Countries (2013-2018)
7.1.2 Europe Influenza Diagnostics Value by Countries (2013-2018)
7.2 Europe Influenza Diagnostics Consumption by Type
7.3 Europe Influenza Diagnostics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Diagnostics by Countries
8.1.1 Middle East & Africa Influenza Diagnostics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Influenza Diagnostics Value by Countries (2013-2018)
8.2 Middle East & Africa Influenza Diagnostics Consumption by Type
8.3 Middle East & Africa Influenza Diagnostics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Influenza Diagnostics Distributors
10.3 Influenza Diagnostics Customer
11 GLOBAL INFLUENZA DIAGNOSTICS MARKET FORECAST
11.1 Global Influenza Diagnostics Consumption Forecast (2018-2023)
11.2 Global Influenza Diagnostics Forecast by Regions
11.2.1 Global Influenza Diagnostics Forecast by Regions (2018-2023)
11.2.2 Global Influenza Diagnostics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Influenza Diagnostics Forecast by Type
11.8 Global Influenza Diagnostics Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 BD
12.1.1 Company Details
12.1.2 Influenza Diagnostics Product Offered
12.1.3 BD Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 BD News
12.2 Abbott (Include Alere)
12.2.1 Company Details
12.2.2 Influenza Diagnostics Product Offered
12.2.3 Abbott (Include Alere) Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Abbott (Include Alere) News
12.3 Roche
12.3.1 Company Details
12.3.2 Influenza Diagnostics Product Offered
12.3.3 Roche Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Roche News
12.4 SIEMENS
12.4.1 Company Details
12.4.2 Influenza Diagnostics Product Offered
12.4.3 SIEMENS Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 SIEMENS News
12.5 Analytik Jena
12.5.1 Company Details
12.5.2 Influenza Diagnostics Product Offered
12.5.3 Analytik Jena Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Analytik Jena News
12.6 Quidel
12.6.1 Company Details
12.6.2 Influenza Diagnostics Product Offered
12.6.3 Quidel Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Quidel News
12.7 Thermo Fisher
12.7.1 Company Details
12.7.2 Influenza Diagnostics Product Offered
12.7.3 Thermo Fisher Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Thermo Fisher News
12.8 Meridian Bioscience
12.8.1 Company Details
12.8.2 Influenza Diagnostics Product Offered
12.8.3 Meridian Bioscience Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Meridian Bioscience News
12.9 BioMerieux
12.9.1 Company Details
12.9.2 Influenza Diagnostics Product Offered
12.9.3 BioMerieux Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 BioMerieux News
12.10 Sekisui Diagnostics
12.10.1 Company Details
12.10.2 Influenza Diagnostics Product Offered
12.10.3 Sekisui Diagnostics Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Sekisui Diagnostics News
12.11 Response Biomedical
12.12 SA Scientific
12.13 Enigma Diagnostics
12.14 Focus Diagnostics
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Diagnostics Consumption 2013-2023
2.1.2 Influenza Diagnostics Consumption CAGR by Region
2.2 Influenza Diagnostics Segment by Type
2.2.1 RIDT
2.2.2 RT-PCR
2.2.3 Cell Culture
2.3 Influenza Diagnostics Consumption by Type
2.3.1 Global Influenza Diagnostics Consumption Market Share by Type (2013-2018)
2.3.2 Global Influenza Diagnostics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Influenza Diagnostics Sale Price by Type (2013-2018)
2.4 Influenza Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 POCT
2.4.3 Others (Laboratory diagnosis, etc.)
2.5 Influenza Diagnostics Consumption by Application
2.5.1 Global Influenza Diagnostics Consumption Market Share by Application (2013-2018)
2.5.2 Global Influenza Diagnostics Value and Market Share by Application (2013-2018)
2.5.3 Global Influenza Diagnostics Sale Price by Application (2013-2018)
3 GLOBAL INFLUENZA DIAGNOSTICS BY PLAYERS
3.1 Global Influenza Diagnostics Sales Market Share by Players
3.1.1 Global Influenza Diagnostics Sales by Players (2016-2018)
3.1.2 Global Influenza Diagnostics Sales Market Share by Players (2016-2018)
3.2 Global Influenza Diagnostics Revenue Market Share by Players
3.2.1 Global Influenza Diagnostics Revenue by Players (2016-2018)
3.2.2 Global Influenza Diagnostics Revenue Market Share by Players (2016-2018)
3.3 Global Influenza Diagnostics Sale Price by Players
3.4 Global Influenza Diagnostics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Influenza Diagnostics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Influenza Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 INFLUENZA DIAGNOSTICS BY REGIONS
4.1 Influenza Diagnostics by Regions
4.1.1 Global Influenza Diagnostics Consumption by Regions
4.1.2 Global Influenza Diagnostics Value by Regions
4.2 Americas Influenza Diagnostics Consumption Growth
4.3 APAC Influenza Diagnostics Consumption Growth
4.4 Europe Influenza Diagnostics Consumption Growth
4.5 Middle East & Africa Influenza Diagnostics Consumption Growth
5 AMERICAS
5.1 Americas Influenza Diagnostics Consumption by Countries
5.1.1 Americas Influenza Diagnostics Consumption by Countries (2013-2018)
5.1.2 Americas Influenza Diagnostics Value by Countries (2013-2018)
5.2 Americas Influenza Diagnostics Consumption by Type
5.3 Americas Influenza Diagnostics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Influenza Diagnostics Consumption by Countries
6.1.1 APAC Influenza Diagnostics Consumption by Countries (2013-2018)
6.1.2 APAC Influenza Diagnostics Value by Countries (2013-2018)
6.2 APAC Influenza Diagnostics Consumption by Type
6.3 APAC Influenza Diagnostics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Influenza Diagnostics by Countries
7.1.1 Europe Influenza Diagnostics Consumption by Countries (2013-2018)
7.1.2 Europe Influenza Diagnostics Value by Countries (2013-2018)
7.2 Europe Influenza Diagnostics Consumption by Type
7.3 Europe Influenza Diagnostics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Diagnostics by Countries
8.1.1 Middle East & Africa Influenza Diagnostics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Influenza Diagnostics Value by Countries (2013-2018)
8.2 Middle East & Africa Influenza Diagnostics Consumption by Type
8.3 Middle East & Africa Influenza Diagnostics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Influenza Diagnostics Distributors
10.3 Influenza Diagnostics Customer
11 GLOBAL INFLUENZA DIAGNOSTICS MARKET FORECAST
11.1 Global Influenza Diagnostics Consumption Forecast (2018-2023)
11.2 Global Influenza Diagnostics Forecast by Regions
11.2.1 Global Influenza Diagnostics Forecast by Regions (2018-2023)
11.2.2 Global Influenza Diagnostics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Influenza Diagnostics Forecast by Type
11.8 Global Influenza Diagnostics Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 BD
12.1.1 Company Details
12.1.2 Influenza Diagnostics Product Offered
12.1.3 BD Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 BD News
12.2 Abbott (Include Alere)
12.2.1 Company Details
12.2.2 Influenza Diagnostics Product Offered
12.2.3 Abbott (Include Alere) Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Abbott (Include Alere) News
12.3 Roche
12.3.1 Company Details
12.3.2 Influenza Diagnostics Product Offered
12.3.3 Roche Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Roche News
12.4 SIEMENS
12.4.1 Company Details
12.4.2 Influenza Diagnostics Product Offered
12.4.3 SIEMENS Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 SIEMENS News
12.5 Analytik Jena
12.5.1 Company Details
12.5.2 Influenza Diagnostics Product Offered
12.5.3 Analytik Jena Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Analytik Jena News
12.6 Quidel
12.6.1 Company Details
12.6.2 Influenza Diagnostics Product Offered
12.6.3 Quidel Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Quidel News
12.7 Thermo Fisher
12.7.1 Company Details
12.7.2 Influenza Diagnostics Product Offered
12.7.3 Thermo Fisher Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Thermo Fisher News
12.8 Meridian Bioscience
12.8.1 Company Details
12.8.2 Influenza Diagnostics Product Offered
12.8.3 Meridian Bioscience Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Meridian Bioscience News
12.9 BioMerieux
12.9.1 Company Details
12.9.2 Influenza Diagnostics Product Offered
12.9.3 BioMerieux Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 BioMerieux News
12.10 Sekisui Diagnostics
12.10.1 Company Details
12.10.2 Influenza Diagnostics Product Offered
12.10.3 Sekisui Diagnostics Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Sekisui Diagnostics News
12.11 Response Biomedical
12.12 SA Scientific
12.13 Enigma Diagnostics
12.14 Focus Diagnostics
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of Influenza Diagnostics
Table Product Specifications of Influenza Diagnostics
Figure Influenza Diagnostics Report Years Considered
Figure Market Research Methodology
Figure Globa
Figure Picture of Influenza Diagnostics
Table Product Specifications of Influenza Diagnostics
Figure Influenza Diagnostics Report Years Considered
Figure Market Research Methodology
Figure Globa
